View Clinical Trial (Medical Research Study)
Evaluation For NIDCD Head And Neck Surgery Branch Clinical Research Protocols
| City: |
|
Bethesda |
| State: |
|
Maryland |
| Zip Code: |
|
20892 |
| Conditions: |
|
Head and Neck Cancer |
| Purpose: |
|
RATIONALE: Evaluating patients for eligibility in clinical trials may help doctors plan more
effective surgery for patients who have cancer.
PURPOSE: This screening trial is determining the eligibility of patients to participate in
head and neck surgery clinical trials at the National Institute on Deafness and Other
Communication Disorders and National Cancer Institute.
|
| Study Summary: |
|
OBJECTIVES:
- Evaluate eligibility of patients with neoplastic disease of the head and neck for
clinical research protocols at the National Institute on Deafness and Other
Communication Disorders Head and Neck Surgery Branch and National Cancer Institute.
OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine
protocol eligibility. The procedures and testing may include, but are not limited to,
laboratory blood tests, including HLA typing, hepatitis screening, and HIV serology; various
nuclear medicine and imaging scans with or without contrast dye; pulmonary function tests;
endoscopy; incisional or excisional biopsy; fine-needle aspiration; and arteriogram.
PROJECTED ACCRUAL: A maximum of 300 patients will be accrued for this study within 5 years.
|
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Histologically confirmed or suspected neoplastic disease of the head and neck with 1
of the following histological subtypes:
- Squamous cell carcinoma
- Verrucous carcinoma
PATIENT CHARACTERISTICS:
Age
- Any age
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Concurrent chemotherapy allowed
Endocrine therapy
- Not specified
Radiotherapy
- Concurrent radiotherapy allowed
Surgery
- No concurrent surgical procedure except those required by a screening test or biopsy
on this study
|
| NCT ID: |
|
NCT00045071 |
| Primary Contact: |
|
Study Chair
Carter Van Waes, MD, PhD
National Institute on Deafness and Other Communication Disorders (NIDCD)
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Bethesda, Maryland 20892
United States
Clinical Trials Office - Warren Grant Magnusen Clinical Center
Phone: 888-NCI-1937
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 22, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|